Tazarotene Patent Expiration
Tazarotene is Used for treating acne vulgaris in patients 12 years of age or older. It was first introduced by Allergan Inc
Tazarotene Patents
Given below is the list of patents protecting Tazarotene, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Arazlo | US11311482 | Topical compositions and methods for treating skin diseases | May 11, 2038 | Bausch |
| Arazlo | US12128137 | Topical compositions and methods for treating skin diseases | May 11, 2038 | Bausch |
| Arazlo | US11679116 | Topical compositions and methods for treating psoriasis | Jun 06, 2036 | Bausch |
| Fabior | US10568859 | Topical foam composition | Feb 24, 2030 | Mayne Pharma |
| Fabior | US10688071 | Topical foam composition | Feb 24, 2030 | Mayne Pharma |
| Fabior | US8808716 | Topical foam composition | Feb 24, 2030 | Mayne Pharma |
| Arazlo | US6517847 | Topical gel delivery system |
Aug 03, 2020
(Expired) | Bausch |
| Tazorac | US5914334 | Stable gel formulation for topical treatment of skin conditions |
Jun 07, 2014
(Expired) | Allergan |
| Tazorac | US6258830 | Stable gel formulation for topical treatment of skin conditions |
Jun 07, 2014
(Expired) | Allergan |
Tazarotene's Family Patents
Explore Our Curated Drug Screens
Tazarotene Generic API Manufacturers
Several generic applications have been filed for Tazarotene. The first generic version for Tazarotene was by Taro Pharmaceuticals Inc and was approved on Apr 3, 2017. And the latest generic version is by Cosette Pharmaceuticals Inc and was approved on Mar 10, 2025.
Given below is the list of companies who have filed for Tazarotene generic, along with the locations of their manufacturing plants worldwide.
1. COSETTE
Cosette Pharmaceuticals Inc has filed for 2 different strengths of generic version for Tazarotene. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Prescription | TOPICAL | AB | Sep 13, 2022 |
| 0.05% | cream | Prescription | TOPICAL | AB | Mar 10, 2025 |
Manufacturing Plant Locations New
Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
2. FOUGERA PHARMS INC
Fougera Pharmaceuticals Inc has filed for 1 generic for Tazarotene. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | cream | Discontinued | TOPICAL | N/A | Jan 28, 2019 |
3. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Tazarotene. Given below are the details of the strengths of this generic introduced by Padagis Israel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Prescription | TOPICAL | AB | Apr 25, 2023 |
| 0.05% | cream | Prescription | TOPICAL | AB | Jul 15, 2024 |
Manufacturing Plant Locations New
Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| Israel |
| |||
4. SOLARIS PHARMA CORP
Solaris Pharma Corp has filed for 2 different strengths of generic version for Tazarotene. Given below are the details of the strengths of this generic introduced by Solaris Pharma Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Prescription | TOPICAL | AB | Mar 20, 2023 |
| 0.05% | gel | Prescription | TOPICAL | AB | Mar 20, 2023 |
Manufacturing Plant Locations New
Solaris Pharma Corp's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Solaris Pharma Corp as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
5. TARO
Taro Pharmaceuticals Inc has filed for 1 generic for Tazarotene. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | cream | Prescription | TOPICAL | AB | Apr 3, 2017 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||